- Home
- DIBS vs MNOV Comparison
DIBS vs MNOV Comparison
Compare DIBS & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIBS
- MNOV
- Stock Information
- Founded
- DIBS 2000
- MNOV 2000
- Country
- DIBS United States
- MNOV United States
- Employees
- DIBS 284
- MNOV N/A
- Industry
- DIBS Catalog/Specialty Distribution
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- DIBS Consumer Discretionary
- MNOV Health Care
- Exchange
- DIBS Nasdaq
- MNOV Nasdaq
- Market Cap
- DIBS 86.4M
- MNOV 76.0M
- IPO Year
- DIBS 2021
- MNOV 2005
- Fundamental
- Price
- DIBS $2.45
- MNOV $1.45
- Analyst Decision
- DIBS Hold
- MNOV Strong Buy
- Analyst Count
- DIBS 1
- MNOV 1
- Target Price
- DIBS N/A
- MNOV $9.00
- AVG Volume (30 Days)
- DIBS 123.8K
- MNOV 16.4K
- Earning Date
- DIBS 05-09-2025
- MNOV 05-08-2025
- Dividend Yield
- DIBS N/A
- MNOV N/A
- EPS Growth
- DIBS N/A
- MNOV N/A
- EPS
- DIBS N/A
- MNOV N/A
- Revenue
- DIBS $88,257,000.00
- MNOV N/A
- Revenue This Year
- DIBS $5.47
- MNOV N/A
- Revenue Next Year
- DIBS $6.46
- MNOV N/A
- P/E Ratio
- DIBS N/A
- MNOV N/A
- Revenue Growth
- DIBS 4.22
- MNOV N/A
- 52 Week Low
- DIBS $2.30
- MNOV $1.12
- 52 Week High
- DIBS $6.20
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- DIBS 31.53
- MNOV 50.85
- Support Level
- DIBS $2.33
- MNOV $1.36
- Resistance Level
- DIBS $2.49
- MNOV $1.35
- Average True Range (ATR)
- DIBS 0.20
- MNOV 0.09
- MACD
- DIBS -0.00
- MNOV 0.03
- Stochastic Oscillator
- DIBS 17.34
- MNOV 91.43
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The Company has a single reportable and operating segment that contains one reporting unit, which consists of the Company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.